Publications and Investor Resources
Publications and Investor Resources
UTILITY therapeutics is a biotechnology company focused on the US development and commercialization of 2 European-approved antibiotics, pivmecillinam and mecillinam, for the treatment of urinary tract infections.
Our approach is to identify exceptional candidates who meet urgent needs and draw on our expertise to expedite approval and make new options available to healthcare professionals and patients as quickly as possible.